Recommendations of the Canadian Consensus Group on the Management of Chronic Myeloid Leukemia

Chronic myelogenous leukemia (cml) is a disease characterized by the expression of Bcr/Abl, an oncogenic protein tyrosine kinase, and by evolution over time from a relatively benign chronic phase to a rapidly fatal cml blast crisis. Until recently, the standard of care included potentially curative...

Descripción completa

Detalles Bibliográficos
Autores principales: Laneuville, P., Barnett, M.J., Bélanger, R., Couban, S., Forrest, D.L., Roy, D.C., Lipton, J.H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Multimed Inc. 2006
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394607/
https://www.ncbi.nlm.nih.gov/pubmed/22792021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394607/
https://www.ncbi.nlm.nih.gov/pubmed/22792021

Ejemplares similares